| EMAS position statement: management of uterine fibroids FR Pérez-López, L Ornat, I Ceausu, H Depypere, CT Erel, ... Maturitas 79 (1), 106-116, 2014 | 170 | 2014 |
| Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement P Anagnostis, SA Paschou, G Mintziori, I Ceausu, H Depypere, ... Maturitas 101, 23-30, 2017 | 125 | 2017 |
| EMAS position statement: the ten point guide to the integral management of menopausal health M Neves-e-Castro, M Birkhauser, G Samsioe, I Lambrinoudaki, ... Maturitas 81 (1), 88-92, 2015 | 119 | 2015 |
| EMAS position statement: non-hormonal management of menopausal vasomotor symptoms G Mintziori, I Lambrinoudaki, DG Goulis, I Ceausu, H Depypere, CT Erel, ... Maturitas 81 (3), 410-413, 2015 | 113 | 2015 |
| EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy TF Rees M, Pérez-López FR, Ceasu I, Depypere H, Erel T, Lambrinoudaki I ... Maturitas 73 (2), 171-4, 2012 | 91 | 2012 |
| Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS) E Armeni, I Lambrinoudaki, I Ceausu, H Depypere, A Mueck, ... Maturitas 89, 63-72, 2016 | 87 | 2016 |
| EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women E Dreisler, LG Poulsen, SL Antonsen, I Ceausu, H Depypere, CT Erel, ... Maturitas 75 (2), 181-190, 2013 | 84 | 2013 |
| Menopause symptom management in women with dyslipidemias: An EMAS clinical guide P Anagnostis, J Bitzer, A Cano, I Ceausu, P Chedraui, F Durmusoglu, ... Maturitas 135, 82-88, 2020 | 74 | 2020 |
| EMAS position statement: Testosterone replacement therapy in the aging male C Dimopoulou, I Ceausu, H Depypere, I Lambrinoudaki, A Mueck, ... Maturitas 84, 94-99, 2016 | 73 | 2016 |
| EMAS recommendations for conditions in the workplace for menopausal women A Griffiths, I Ceausu, H Depypere, I Lambrinoudaki, A Mueck, ... Maturitas 85, 79-81, 2016 | 65 | 2016 |
| Osteoporosis management in patients with breast cancer: EMAS position statement FA Trémollieres, I Ceausu, H Depypere, I Lambrinoudaki, A Mueck, ... Maturitas 95, 65-71, 2017 | 53 | 2017 |
| Management of depressive symptoms in peri-and postmenopausal women: EMAS position statement P Stute, A Spyropoulou, V Karageorgiou, A Cano, J Bitzer, I Ceausu, ... Maturitas 131, 91-101, 2020 | 52 | 2020 |
| The Mediterranean diet and menopausal health: An EMAS position statement A Cano, S Marshall, I Zolfaroli, J Bitzer, I Ceausu, P Chedraui, ... Maturitas 139, 90-97, 2020 | 47 | 2020 |
| EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women FR Pérez-López, I Ceausu, H Depypere, CT Erel, I Lambrinoudaki, ... Maturitas 74 (3), 279-282, 2013 | 45 | 2013 |
| EMAS position statement: Diet and health in midlife and beyond. PLFR Lambrinoudaki I, Ceasu I, Depypere H, Erel T, Rees M, Schenck ... Maturitas. 74 (1), 99-104, 2013 | 45 | 2013 |
| Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide AL Hirschberg, J Bitzer, A Cano, I Ceausu, P Chedraui, F Durmusoglu, ... Maturitas 148, 55-61, 2021 | 41 | 2021 |
| Management of urinary incontinence in postmenopausal women: An EMAS clinical guide E Russo, M Caretto, A Giannini, J Bitzer, A Cano, I Ceausu, P Chedraui, ... Maturitas 143, 223-230, 2021 | 41 | 2021 |
| A model of care for healthy menopause and ageing: EMAS position statement P Stute, I Ceausu, H Depypere, I Lambrinoudaki, A Mueck, ... Maturitas 92, 1-6, 2016 | 39 | 2016 |
| Neuroimaging parameters in early open spina bifida detection. Further benefit in first trimester screening D Iliescu, A Comănescu, P Antsaklis, S Tudorache, M Ghiluşi, ... Rom J Morphol Embryol 52 (3), 809-817, 2011 | 35 | 2011 |
| The hysterectomized woman: is she special? The women's health in the Lund area (WHILA) study I Ceausu, YA Shakir, J Lidfeldt, G Samsioe, C Nerbrand Maturitas 53 (2), 201-209, 2006 | 34 | 2006 |
